OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced the commercial launch of its ICE COLD-PCR mutation detection technology, a breakthrough technology enabling unmatched sensitivity and complete DNA mutation detection using the standard sequencing equipment already installed in laboratories around the world. The launch coincides with the 2012 annual meeting of the American Society of […]
Waltham, Mass. – PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that the Company is hosting the Revolutionaries for Global Health Summit. With the first 2012 event beginning on June 7th, PerkinElmer has assembled thought leader forums across several disciplines in human health, to […]
NEW YORK — Exosome Diagnostics today announced it has reached agreement with Life Technologies to use the Applied Biosystems® (ABI) 7500 Fast Dx Real-Time PCR Instrument for the Company’s exosome biofluid in-vitro diagnostics oncology program. Exosome Diagnostics plans to validate the ABI instrument platform with exosome biofluid RNA isolation technology kits in upcoming multi-center clinical […]
MADISON, N.J., — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed to be the most comprehensive panel clinically available to identify mutations associated […]
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the launch of its ColoPrint microarray-based 18-gene expression signature for predicting the risk of distant recurrence for stage II colon cancer patients who have undergone surgery. ColoPrint provides a definitive relapse risk assessment for […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) will exhibit platforms for companion diagnostic development and products ideal for basic, translational and clinical cancer research during the American Society for Clinical Oncology (ASCO) Annual Meeting 2012, taking place June 1 — June 5, in Chicago, Illinois. In addition, several of the company’s customers will present […]
REDWOOD CITY, Calif. – Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that physicians across the country are now using the verifi™ prenatal test. In addition, the company will be presenting two key studies demonstrating the company’s proprietary method to detect chromosomal abnormalities across the entire genome at the […]
IRVINE, CA and AMSTERDAM, THE NETHERLANDS,– Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced that the company has raised USD $65 million in a private round of equity financing. “The support we have received in this round of financing is a strong reflection of our recent growth and confidence […]
Carlsbad, CA, — Olympus Europa Holding GmbH and Applied Spectral Imaging (ASI) Ltd. today signed a European framework agreement outlining the terms for distribution by Olympus subsidiaries in Europe of the GenASIs automated imaging platforms for genetic and pathological analysis. This agreement underlines both companies’ intent to establish cooperation with individual Olympus distributors in Europe. […]
Budapest, Hungary,- Today Omixon – a genomic software company – announced the commercial release of Omixon Target, a next generation sequencing analysis software for targeted sequencing. Omixon built its new software Target with the vision of helping diagnostic labs to adopt next generation sequencing to replace and complement traditional capillary Sanger sequencing. Target was built […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
